Endocrinology
FDA/CDC
FDA okays new indication for alirocumab in homozygous FH
The FDA approved use of the PCSK9 inhibitor as an add-on therapy in adults with rare homozygous familial hypercholesterolemia.
News
Use of complimentary and alternative medicine common in diabetes patients
Roughly half of diabetes patients may be using complementary and alternative medicine, but most don’t tell their healthcare providers.
Conference Coverage
COVID-19 can cause atypical thyroid inflammation
Patients with thyroid abnormalities during acute COVID-19, or who develop such symptoms, should have thyroid function checked every 6 months for a...
News
Women with PCOS at increased risk for COVID-19
Women with PCOS may fear an increased infection risk "will further compromise timely access to health care and serve to increase the sense of...
News
Diabetes prevention moves toward reality as studies published
Newly published 3-year data on teplizumab in high-risk individuals and combination therapy with liraglutide in new-onset type 1 diabetes show...
News
Ultraprocessed foods, many marketed as healthy, raise CVD risk
News
Abdominal aortic calcification may further raise known fracture risk
Men with a prevalent vertebral fracture on lateral spine radiograph had even greater risk for future osteoporotic fractures with increasing...
News
High obesity rates in Southern states magnify COVID threats
At least 29 states have green-lighted obesity for inclusion in the first phases of the COVID-19 vaccine rollout. That could overwhelm government...
News
Eating fish tied to fewer CVD events in high-risk people
A report shows a significant link between eating two fish meals a week and fewer cardiovascular disease events for those with or at high risk for...
News
Don’t discontinue osteoporosis meds for COVID-19 vaccines, expert guidance says
Recommendations help physicians distinguish between a reaction to the vaccine and a reaction to medication.